MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.psychres.2011.09.005

Медицинская библиотека · Psychiatry research · 2012

Patterns of serotonergic antidepressant usage in prodromal Huntington disease.

Rowe Kelly C, Paulsen Jane S, Langbehn Douglas R, Wang Chiachi, Mills James, Beglinger Leigh J, Smith Megan M, Epping Eric A, Fiedorowicz Jess G, Duff Kevin, Ruggle Adam, Moser David J, PREDICT-HD Investigators of the Huntington Study Group

СтатьяМногоцентровое исследованиеПоддержка NIH: внешняя программаПеревод пока не подготовлен

Аннотация

Antidepressant usage in prodromal Huntington Disease (HD) remains uncharacterized, despite its relevance in designing experiments, studying outcomes of HD, and evaluating the efficacy of therapeutic interventions. We searched baseline medication logs of 787 prodromal HD and 215 healthy comparison (HC) participants for antidepressant use. Descriptive and mixed-effects logistic regression modeling characterized usage across participants. At baseline, approximately one in five prodromal HD participants took antidepressants. Of those, the vast majority took serotonergic antidepressants (selective serotonin reuptake inhibitor (SSRI) or serotonin/norepinephrine reuptake inhibitor (SNRI)). Significantly more prodromal HD participants used serotonergic antidepressants than their HC counterparts. Because of the prevalence of these medications, further analyses focused on this group alone. Mixed-effects logistic regression modeling revealed significant relationships of both closer proximity to diagnosis and female sex with greater likelihood to be prescribed a serotonergic antidepressant. More prodromal HD participants took antidepressants in general and specifically the subclass of serotonergic antidepressants than their at-risk counterparts, particularly when they were closer to predicted time of conversion to manifest HD. These propensities must be considered in studies of prodromal HD participants.

Для цитирования: Rowe Kelly C, Paulsen Jane S, Langbehn Douglas R, Wang Chiachi, Mills James, Beglinger Leigh J, Smith Megan M, Epping Eric A, Fiedorowicz Jess G, Duff Kevin, Ruggle Adam, Moser David J, PREDICT-HD Investigators of the Huntington Study Group. Patterns of serotonergic antidepressant usage in prodromal Huntington disease.. Psychiatry research. 2012. DOI: 10.1016/j.psychres.2011.09.005.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.